Herb Profile

Pueraria Lobata

Pueraria lobata

Pueraria Lobata (Pueraria lobata) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Caution with hormone sensitive conditions, estrogenic therapies, anticoagulants/antiplatelets, antihypertensives, diabetes medications, pregnancy, and breastfeeding. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Hormonal, Metabolic
Avoid / review if
Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Hormone Sensitive Conditions Without Clinician Review
Pueraria Lobata monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Caution with hormone-sensitive conditions, estrogenic therapies, anticoagulants/antiplatelets, antihypertensives, diabetes medications, pregnancy, and breastfeeding.
Profile context
hormonal, metabolic
Next steps

Continue reading

  • If you want to browse more herbsAll herbs

Safety

Safety & Cautions

Caution with hormone sensitive conditions, estrogenic therapies, anticoagulants/antiplatelets, antihypertensives, diabetes medications, pregnancy, and breastfeeding.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Hormonal Activity ContextHormone-adjacent wording is present and should be interpreted carefully.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy/Breastfeeding Without Clinician Supervision
  • Known Allergy To The Plant/Family
  • Hormone Sensitive Conditions Without Clinician Review
  • Potential Interaction Concern With Antidiabetic Medicines
  • Hormonal Therapies
  • Use Clinician Review For High Dose Extracts Or Chronic Use.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Hormonal Activity Context: Hormone-adjacent wording is present and should be interpreted carefully.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • Caution with hormone sensitive conditions, estrogenic therapies, anticoagulants/antiplatelets, antihypertensives, diabetes medications, pregnancy, and breastfeeding.

Safety labels

  • Interaction-Aware
  • Hormonal Activity Context
  • Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedMetabolic Regulation · Hormonal Signaling Context · AMPK Signaling

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableCaution with hormone sensitive conditions, estrogenic therapies, anticoagulants/antiplatelets, antihypertensives, diabetes medications, pregnancy, and breastfeeding.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Narrative review
Risk of Bias
High
Consistency
Not assessed
Strongest recorded design is a narrative review, drawn from 1 recorded study, none of which measured an outcome in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (3)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 3 of 3 studies.

What the evidence actually shows

This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Puerarin: a review of pharmacological effects

Zhou YX et al. · Phytother Res · 2014

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Network Pharmacology and Bioinformatics Study of Six Medicinal Food Homologous Plants Against Colorectal Cancer

Zhao X et al. · Int J Mol Sci · 2025

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Puerarin ameliorates colitis by direct suppression of macrophage M1 polarization in DSS mice

Tao Q et al. · Phytomedicine · 2024

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.
How Pueraria Lobata works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Pueraria Lobata Works

How Pueraria Lobata WorksPueraria Lobata acts on biological target pathways via metabolic (regulation), leading to hormone balance.Pueraria LobataBiological TargetBiological pathwayMetabolicRegulationHormone BalanceEndocrine supportHormonal SignalingContext
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Metabolic Regulation
  • Hormonal Signaling Context
  • AMPK Signaling
  • Glucose Metabolism Support

Active Compounds

Key constituents studied in Pueraria Lobata, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Pueraria Lobata

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Pueraria Lobata research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.